Bryn Mawr, PA, United States of America

Jeffrey M Jonas

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jeffrey M Jonas

Introduction

Jeffrey M Jonas is an accomplished inventor based in Bryn Mawr, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the delivery of poorly water-soluble drugs. His innovative work has the potential to improve treatment options for various disease states.

Latest Patents

Jeffrey M Jonas holds a patent for "Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment." This invention is directed towards compositions comprising suspensions of poorly water-soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 µm. The patent outlines methods for the preparation and administration of these compositions to patients for the prevention and treatment of diseases, particularly chronic conditions such as cancer.

Career Highlights

Throughout his career, Jeffrey has focused on developing innovative solutions to enhance drug delivery systems. His work has been instrumental in advancing the field of nanotechnology in pharmaceuticals. He is currently associated with Crititech, Inc., where he continues to explore new avenues for improving patient care.

Collaborations

Jeffrey has collaborated with notable professionals in his field, including Roger A Rajewski and Bala Subramaniam. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeffrey M Jonas is a prominent inventor whose work in drug delivery systems has the potential to transform treatment methodologies. His contributions to the field are noteworthy and continue to inspire advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…